Finland joins Sweden and Denmark to limit use of Moderna vaccine
October 8, 2021Medical Communications
On Thursday, Finland became the latest country to suspend the use of Moderna’s COVID vaccine on younger males, amid reports …
UN Secretary General makes $8 billion plea to vaccinate 40% of world in 2021
October 8, 2021Medical Communications
UN Secretary-General, Antonio Guterres, appealed on Thursday for $8 billion to help equitably vaccinate 40% of people in all countries …
Women and children most impacted by mental health during pandemic
October 7, 2021Business Services
The Headway 2023 Mental Health Index has revealed that the pandemic has taken a significant toll on the mental health …
Incyte trial reveals encouraging results for patients with vitiligo
October 7, 2021Business Services
Incyte has announced full results from its Phase III TRuE-V Program, evaluating Ruxolitinib Cream in patients with vitiligo. Treatment with …
Nobel Prize awarded to molecule construction champions
October 7, 2021Business Services
Benjamin List and David MacMillan have been awarded the Nobel prize in chemistry, for their construction of a tool used …
Pfizer enlists entire town in Brazil for COVID study
October 7, 2021Research and Development
An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …
WHO rolls out GSK’s malaria vaccine in Africa
October 7, 2021Medical Communications, Research and Development
The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …
Janssen’s bowel disease drug shown to be safe for use in older patients
October 6, 2021Research and Development
The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …
UroGen Pharma shows positive results for bladder cancer patients
October 6, 2021Research and Development
UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …
Third dose of COVID-19 vaccine approved for immunocompromised over 12
October 6, 2021Research and Development
The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
Merck secures Singapore deal for COVID antiviral pill
October 6, 2021Medical Communications, Research and Development
Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …
Bayer wins first court case in Roundup child cancer battle
October 6, 2021Medical Communications, Research and Development
Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …
Transgene and BioInvent to present oncolytic virus data at SITC 2021
October 5, 2021Manufacturing and Production
Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …
AstraZeneca requests emergency authorisation for COVID-19 drug
October 5, 2021Manufacturing and Production
AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …
Kintor begins Phase III trial of proxalutamide for COVID patients in US
October 5, 2021Manufacturing and Production
Chinese clinical-stage drug developer, Kintor Pharmaceutical Ltd, has announced the initiation of the Phase III clinical trial of proxalutamide for …
Brain implant can lift severe depression, study finds
October 5, 2021Manufacturing and Production, Research and Development
Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …
NICE recommends first new sickle cell disease treatment in 20 years
October 5, 2021Manufacturing and Production, Medical Communications, Research and Development
NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …
AlzeCure’s Alzheimer project initiates Phase I study
October 4, 2021Sales and Marketing
Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …
SEED invests in CBD brand business
October 4, 2021Sales and Marketing
SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …
Bayer Phase III trial results prove positive for diabetes patients
October 4, 2021Sales and Marketing
Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
